Leishmania Infection in Suriname
Author Information
Author(s): van der Meide Wendy, de Vries Henry, Pratlong Francine, van der Wal Allard, Sabajo Leslie
Primary Institution: Royal Tropical Institute, Amsterdam, the Netherlands
Hypothesis
What is the clinical response to miltefosine treatment in a patient with cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis?
Conclusion
The patient showed significant clinical improvement and complete resolution of lesions after treatment with miltefosine.
Supporting Evidence
- The patient had a long history of skin lesions consistent with cutaneous leishmaniasis.
- Histopathology confirmed the diagnosis of cutaneous leishmaniasis.
- Miltefosine treatment led to a decrease in parasite counts to zero by day 70.
Takeaway
A 17-year-old boy with a skin disease got better after taking a medicine called miltefosine for his leishmaniasis.
Methodology
The patient was treated with oral miltefosine for 98 days, and skin biopsies were taken to monitor the parasite load.
Limitations
The study is based on a single case, limiting the generalizability of the findings.
Participant Demographics
The patient was a 17-year-old male from Suriname.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website